Quantum Genomics (STU:2QG) COGS-to-Revenue : 0.00 (As of Dec. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Quantum Genomics COGS-to-Revenue?

Quantum Genomics's Cost of Goods Sold for the six months ended in Dec. 2022 was €25.00 Mil. Its Revenue for the six months ended in Dec. 2022 was €-0.29 Mil.

Quantum Genomics's COGS to Revenue for the six months ended in Dec. 2022 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Quantum Genomics's Gross Margin % for the six months ended in Dec. 2022 was %.

Quantum Genomics COGS-to-Revenue Historical Data

The historical data trend for Quantum Genomics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics COGS-to-Revenue Chart

Quantum Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

11.06

159.09

48.76

Quantum Genomics Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
COGS-to-Revenue	Get a 7-Day Free Trial															6.82	0.94	-	5.02	-

Quantum Genomics COGS-to-Revenue Calculation

Quantum Genomics's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	29.502	/	0.605
	=	48.76

Quantum Genomics's COGS to Revenue for the quarter that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	25.002	/	-0.292
	=

Quantum Genomics (STU:2QG) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Quantum Genomics's Gross Margin % for the six months ended in Dec. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	25.002 / -0.292
	=	%

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Quantum Genomics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum Genomics (STU:2QG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (STU:2QG) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

33, Rue Marbeuf, Paris, FRA, 75008

Website

https://quantum-genomics.com

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Quantum Genomics (STU:2QG) Headlines

No Headlines